Mi­nor­i­ty in­vestor Wa­ter­Mill suc­ceeds in ac­tivist at­tack of Zio­pharm, win­ning two board seats and re­moval of chair­man

The ac­tivist at­tack launched at Zio­pharm On­col­o­gy $ZIOP that turned in­to an ug­ly and bit­ter pub­lic feud has come to a con­clu­sion.

Two of the three board nom­i­nees put forth by 3.3% mi­nor­i­ty in­vestor Wa­ter­Mill As­set Man­age­ment Corp. will be join­ing Zio­pharm’s board af­ter re­ceiv­ing the nec­es­sary 50%+ votes from share­hold­ers, Wa­ter­Mill said Thurs­day morn­ing. Ad­di­tion­al­ly, a ma­jor­i­ty of Zio­pharm share­hold­ers vot­ed to re­call chair­man Scott Tar­riff, the firm said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER